Fresh Tracks Therapeutics (STU:VCC) 3-Year EBITDA Growth Rate : 69.90% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Fresh Tracks Therapeutics 3-Year EBITDA Growth Rate?

Fresh Tracks Therapeutics's EBITDA per Share for the three months ended in Dec. 2023 was €-0.19.

During the past 3 years, the average EBITDA Per Share Growth Rate was 69.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 68.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 43.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Fresh Tracks Therapeutics was 71.50% per year. The lowest was -44.40% per year. And the median was 1.30% per year.

Competitive Comparison of Fresh Tracks Therapeutics's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Fresh Tracks Therapeutics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresh Tracks Therapeutics's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fresh Tracks Therapeutics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Fresh Tracks Therapeutics's 3-Year EBITDA Growth Rate falls into.

Fresh Tracks Therapeutics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Fresh Tracks Therapeutics (STU:VCC) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Fresh Tracks Therapeutics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Fresh Tracks Therapeutics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresh Tracks Therapeutics (STU:VCC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fresh Tracks Therapeutics Inc (STU:VCC) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

FRTX:USA

Address

5777 Central Avenue, Suite 102, Boulder, CO, USA, 80301

Website

https://www.frtx.com

Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical company striving to transform patient lives through the development of innovative and differentiated prescription therapeutics.

Fresh Tracks Therapeutics (STU:VCC) Headlines

No Headlines